Your browser doesn't support javascript.
loading
Overnight fasting before lapatinib administration to breast cancer patients leads to reduced toxicity compared with nighttime dosing: a retrospective cohort study from a randomized clinical trial.
Tsuda, Moe; Ishiguro, Hiroshi; Toriguchi, Naoko; Masuda, Norikazu; Bando, Hiroko; Ohgami, Masahiro; Homma, Masato; Morita, Satoshi; Yamamoto, Naohito; Kuroi, Katsumasa; Yanagita, Yasuhiro; Takano, Toshimi; Shimizu, Satoru; Toi, Masakazu.
Affiliation
  • Tsuda M; Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Ishiguro H; Breast Oncology Service, Saitama Medical University International Medical Center, Hidaka, Japan.
  • Toriguchi N; Oncology Products, Medicine Development Unit Japan, Eli Lilly Japan K.K, Kobe, Japan.
  • Masuda N; Department of Surgery, Breast Oncology, NHO Osaka National Hospital, Osaka, Japan.
  • Bando H; Breast and Endocrine Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Ohgami M; Department of Pharmacy, Ibaraki Prefectural Central Hospital, Kasama, Japan.
  • Homma M; Department of Pharmaceutical Sciences, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Morita S; Department of Biomedical Statistics and Bioinformatics. Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Yamamoto N; Division of Breast Surgery, Chiba Cancer Center, Chiba, Japan.
  • Kuroi K; Department of Breast Surgery, Tokyo Metropolitan Health and Hospitals Corporation Ebara Hospital, Tokyo, Japan.
  • Yanagita Y; Department of Breast Oncology, Gunma Prefectural Cancer Center, Gunma, Japan.
  • Takano T; Breast Medical Oncology, Breast Oncology Center, The Cancer Institute Hospital of JFCR, Tokyo, Japan.
  • Shimizu S; Breast and Endocrine Surgery, Kanagawa Cancer Center, Yokohama, Japan.
  • Toi M; Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Cancer Med ; 9(24): 9246-9255, 2020 12.
Article in En | MEDLINE | ID: mdl-33094919

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Fasting / Trastuzumab / Lapatinib Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Aspects: Patient_preference Limits: Female / Humans / Middle aged Language: En Journal: Cancer Med Year: 2020 Document type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Fasting / Trastuzumab / Lapatinib Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Aspects: Patient_preference Limits: Female / Humans / Middle aged Language: En Journal: Cancer Med Year: 2020 Document type: Article Affiliation country: Japan